HealthcareServices

Global Diabetic Kidney Disease Market Forecast 2026–2035: Long-Term Growth Insights

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the diabetic kidney disease market from 2026–2035 with trusted insights from The Business Research Company

How is the Diabetic Kidney Disease Market size predicted to change over the forecast window of 2026–2035?

The market for diabetic kidney disease has experienced robust expansion over recent years. Forecasts indicate it will expand from $2.8 billion in 2025 to reach $2.96 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.9%. Historically, this growth has been driven by factors such as the widespread occurrence of kidney damage associated with diabetes, diagnoses made at advanced disease stages, insufficient adoption of early screening methods, dependence on dialysis for advanced cases, and an increase in hospitalization rates.

The market for diabetic kidney disease is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $3.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the forecast period include progress in renal protective medications, a rise in early diagnosis programs, the increasing prevalence of chronic kidney disease, the expansion of specialized nephrology services, and an emphasis on individualized treatment approaches. Key trends expected throughout the forecast period involve the wider adoption of early renal screening, an uptick in the utilization of renoprotective drug therapies, the broadening of combination treatment methods, a heightened emphasis on delaying disease progression, and the incorporation of multidisciplinary care models.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

Which Drivers Are Contributing To The Expansion Of The Diabetic Kidney Disease Market?

The escalating incidence of chronic kidney disease is anticipated to boost the expansion of the diabetic kidney disease market. Chronic kidney disease (CKD) is characterized as a long-term medical condition leading to a progressive loss of kidney function over time, resulting in various complications such as high blood pressure, anemia, and bone diseases. Addressing chronic kidney diseases requires both diagnostic and therapeutic approaches, ultimately fostering the growth of the diabetic kidney disease market. For example, in June 2023, according to Kidney Research UK, a prominent UK charity, chronic kidney disease (CKD) impacts roughly 7.2 million individuals in the United Kingdom, comprising over 10% of the population. Among this group, 3.25 million are experiencing the most severe phases of the disease, while approximately 3.9 million are in the early stages, which are frequently undiagnosed and asymptomatic. Projections indicate that the total number of people with chronic renal disease in the United Kingdom could reach 7.61 million by 2033. Therefore, the growing prevalence of chronic kidney disease is fueling the growth of the diabetic kidney disease market in the future.

What Segment Categories Are Covered In The Diabetic Kidney Disease Market?

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease

Which Market Trends Are Opening Growth Opportunities In The Diabetic Kidney Disease Market?

Leading companies in the diabetic kidney disease market are increasingly adopting advanced solutions like artificial intelligence (AI)-enabled prognostic platforms to improve early risk assessment, personalized disease management, and long-term patient outcomes. These AI-enabled prognostic platforms function as diagnostic tools, merging blood-based biomarker measurements with machine-learning algorithms to forecast the likelihood of progressive kidney decline. This capability allows for risk-score generation, patient stratification, and early clinical intervention planning. For instance, in June 2023, Renalytix plc, a UK-based diagnostics company, secured U.S. Food and Drug Administration (FDA) De Novo marketing authorization for KidneyIntelX.dkd. This specific AI-driven prognostic platform is designed to evaluate the risk of significant kidney function decline in adults with type 2 diabetes and early-stage chronic kidney disease. The platform incorporates biomarker-integrated machine-learning algorithms, cloud-based workflow integration, and stratified risk reporting. Ultimately, KidneyIntelX.dkd enhances clinical decision-making, supports targeted monitoring strategies, and improves proactive care planning.

Which Major Industry Participants Are Leading The Diabetic Kidney Disease Market Growth?

Major companies operating in the diabetic kidney disease market are AstraZeneca plc, Pfizer Inc., Novartis AG, Bayer AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Abbott Laboratories, Reata Pharmaceuticals Inc., Merck & Co., Mitsubishi Tanabe Pharma Corporation, Johnson & Johnson pvt. Ltd., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., Boehringer Ingelheim International GmbH, Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Diabetic Kidney Disease Market?

North America was the largest region in the diabetic kidney disease market in 2025. The regions covered in the diabetic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Diabetic Kidney Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9932&type=smp

Browse Through More Reports Similar to the Global Diabetic Kidney Disease Market 2026, By The Business Research Company

Rare Kidney Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Chronic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795